MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 08, 2017
WASHINGTON, MARCH 8, 2017—Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign manager and legal policy advisor, delivered the following remarks at the United States Trade Representative's 2017 Special 301 Review hearing today.
 
Good afternoon. I would like to provide testimony on behalf of MSF.
March 02, 2017

In the Petare and La Vega neighborhoods of Caracas, Venezuela, Doctors Without Borders/Médecins Sans Frontières (MSF) offers psychological assistance to victims of violence, including sexual violence. About 45% of patients are minors.

March 02, 2017

Key House subcommittee examined bill today that amends neglected disease innovation incentive program without fixing loopholes abused by pharmaceutical corporations

February 23, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) medical staff who work at projects in the field have seen first-hand the effects of unsafe abortions. 

February 17, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) Infectious Diseases Advisor Rupa Kanapathipillai answers questions about how MSF sees the global threat of antibiotic resistance at its projects around the world.

What does antibiotic resistance look like in MSF’s field projects?

I’ll give you an example. MSF runs a reconstructive surgical program in Amman, Jordan, for patients from neighboring countries—Iraq, Syria, and Yemen. They’ve often had multiple surgeries and have received courses of various antibiotics before coming to us.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

January 28, 2017

NEW YORK, JANUARY 28, 2017—President Donald J. Trump’s executive order suspending refugee resettlement to the United States is an inhumane act against people fleeing war zones, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, calling for a resumption of refugee resettlement.

January 27, 2017

KRVS talks with Doctors Without Borders/Médecins Sans Frontières (MSF) recruitment officer, Rogier Van Helmond, about recruiting in Lafayette, Louisiana, and MSF's need for french speaking professionals. View external media.

Read More: Work in the Field

Pages

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 08, 2017
WASHINGTON, MARCH 8, 2017—Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign manager and legal policy advisor, delivered the following remarks at the United States Trade Representative's 2017 Special 301 Review hearing today.
 
Good afternoon. I would like to provide testimony on behalf of MSF.
March 02, 2017

In the Petare and La Vega neighborhoods of Caracas, Venezuela, Doctors Without Borders/Médecins Sans Frontières (MSF) offers psychological assistance to victims of violence, including sexual violence. About 45% of patients are minors.

March 02, 2017

Key House subcommittee examined bill today that amends neglected disease innovation incentive program without fixing loopholes abused by pharmaceutical corporations

February 23, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) medical staff who work at projects in the field have seen first-hand the effects of unsafe abortions. 

February 17, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) Infectious Diseases Advisor Rupa Kanapathipillai answers questions about how MSF sees the global threat of antibiotic resistance at its projects around the world.

What does antibiotic resistance look like in MSF’s field projects?

I’ll give you an example. MSF runs a reconstructive surgical program in Amman, Jordan, for patients from neighboring countries—Iraq, Syria, and Yemen. They’ve often had multiple surgeries and have received courses of various antibiotics before coming to us.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

January 28, 2017

NEW YORK, JANUARY 28, 2017—President Donald J. Trump’s executive order suspending refugee resettlement to the United States is an inhumane act against people fleeing war zones, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, calling for a resumption of refugee resettlement.

January 27, 2017

KRVS talks with Doctors Without Borders/Médecins Sans Frontières (MSF) recruitment officer, Rogier Van Helmond, about recruiting in Lafayette, Louisiana, and MSF's need for french speaking professionals. View external media.

Read More: Work in the Field

Pages